Document is current
Any future updates will be listed below
-
Authors
El-Hamdi, Nadia S.
Villamaria, Emma E.
Goldfarb, Noah
Van der Zee, Hessel H.
Garg, Amit
Frew, John
Sabat, Robert
Alavi, Afsaneh
- License Information
-
More Information
Article History
Received: 27 September 2025
Accepted: 6 January 2026
First Online: 21 March 2026
Declarations
:
: Dr. Alavi serves as the board member of Hidradenitis suppurativa Foundation, received grants from NIH, HSF, La Roche-Posay, serves as the chair of Independent Data Monitoring: InflaRX, Almirall, Zura bio and consultant for AbbVie, Almirall, Avalo, BI, Cantargia, InflaRx, Incyte, Leo, Sanofi, Navigator, Novartis, UCB and Investigator for BI and Processa. Dr. Sabat has received research grants, clinical trial contracts, scientific awards, or honoraria for consulting, participation in advisory boards, or for lectures for one or more of the following: AbbVie, Almirall Hermal, Amgen, Bayer Schering Pharma, Boehringer Ingelheim Pharma, Bruno Bloch Stiftung, Celgene/Amgen, Celgene/Bristol Myers Squibb, Charité Research Organisation, CSL Behring, ICON, IQVIA RDS, Incyte, Janssen-Cilag/Janssen Research & Development, MoonLake Immunotherapeutics, Novartis Pharma, Parexel, Rheinischen Friedrich-Wilhelms-Universität Bonn, Sanofi–Aventis, TFS, UCB Biopharma, Universitätsmedizin Greifswald, Wundnetz Berlin-Brandenburg e. V. Dr. van der Zee has received honoraria from AbbVie, Novartis, UCB.
